Patents Assigned to MELIOR DISCOVERY, INC.
  • Methods for treating inflammatory conditions
    Patent number: 9408844
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: August 9, 2016
    Assignee: Melior Discovery, Inc.
    Inventors: Andrew Reaume, Heather Hain, Michael S. Saporito
  • Methods of treating dyskinesia and related disorders
    Patent number: 9402830
    Abstract: The present disclosure describes compounds and pharmaceutically acceptable salts thereof and compositions and formulations comprising the same that are useful in methods of treating dyskinesia or related disorders, and methods for treating dyskinesia or related disorders.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: August 2, 2016
    Assignee: Melior Discovery, Inc.
    Inventors: John Ciallella, John Gruner, Andrew G. Reaume, Michael S. Saporito
  • Methods of treating dyskinesia and related disorders
    Patent number: 9051312
    Abstract: The present disclosure describes compounds and pharmaceutically acceptable salts thereof and compositions and formulations comprising the same that are useful in methods of treating dyskinesia or related disorders, and methods for treating dyskinesia or related disorders.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: June 9, 2015
    Assignee: Melior Discovery, Inc.
    Inventors: John Ciallella, John Gruner, Andrew G. Reaume, Michael S. Saporito
  • Methods For Treating Inflammatory Conditions
    Publication number: 20140227209
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.
    Type: Application
    Filed: April 17, 2014
    Publication date: August 14, 2014
    Applicant: Melior Discovery, Inc.
    Inventors: Andrew Reaume, Heather Hain, Michael S. Saporito
  • Methods for treating inflammatory conditions
    Patent number: 8716294
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.
    Type: Grant
    Filed: November 9, 2007
    Date of Patent: May 6, 2014
    Assignee: Melior Discovery, Inc.
    Inventors: Andrew Reaume, Heather Hain, Michael Saporito
  • Compounds And Methods For Treating Disorders Related To Glucose Metabolism
    Publication number: 20100004273
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof, and compositions comprising the same, that are useful in modulating lyn kinase activity, treating obesity, type II diabetes, metabolic syndrome, and in reducing blood glucose level, weight gain, or fat depot level, or treating a disease or condition associated with the same.
    Type: Application
    Filed: July 1, 2009
    Publication date: January 7, 2010
    Applicant: MELIOR DISCOVERY, INC.
    Inventors: Andrew G. Reaume, Michael S. Saporito, Alexander R. Ochman, Christopher A. Lipinski
  • Methods For Treating Inflammatory Conditions
    Publication number: 20080161319
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.
    Type: Application
    Filed: November 9, 2007
    Publication date: July 3, 2008
    Applicant: MELIOR DISCOVERY, INC.
    Inventors: Andrew Reaume, Heather Hain, Michael Saporito